Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

AIM OF THE STUDY: The majority of patients with chronic myeloid leukaemia (CML) respond to tyrosine kinase inhibitors (TKI), while allogeneic haematopoietic cell transplantation (HCT) is indicated in selected clinical situations. HCT carries the risk of severe complications, while the toxicity profi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Contemp Oncol (Pozn)
Autors principals: Piekarska, Agnieszka, Gil, Lidia, Jakitowicz, Karolina, Prejzner, Witold, Komarnicki, Mieczysław, Hellmann, Andrzej
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2016
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5371710/
https://ncbi.nlm.nih.gov/pubmed/28373825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2016.64607
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars